Clinical Trials in Boston

Showing 7781-7800 of 17,836 trials

Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma

NCT02036476

This is an open-label, non-randomized, phase 2 study to assess the feasibility of using cabozantinib in recurrent/metastatic Merkel Cell Carcinoma patients that progressed after platinum-based therapy.

Merkel Cell CarcinomaSkin Cancer

Dana-Farber Cancer Institute8 participantsStarted Feb 2014

Boston, Massachusetts, United States • Boston, Massachusetts, United States

COMPLETEDNA< 1 mile

ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent

NCT02574481

The primary objective of this trial is to evaluate the safety and effectiveness of the Boston Scientific Corporation (BSC) ELUVIA Drug-Eluting Vascular Stent System (ELUVIA Stent) for treating Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA) lesions up to 140 mm in length. Long Lesion Substudy: to evaluate the safety and effectiveness of the Boston Scientific Corporation (BSC) ELUVIA Drug-Eluting Vascular Stent System (ELUVIA Stent) for treating Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA) lesions \>140 mm and ≤ 190 mm in length.

Atherosclerosis of Native Arteries of the Extremities

Boston Scientific Corporation524 participantsStarted Dec 2015

Yuma, Arizona, United States • Sacramento, California, United States • Gainesville, Florida, United States +65 more locations

Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma

ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent

Find Trials by Condition in Boston

The T1D Exchange Registry

MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)

Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)

Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Eye Movement Rehabilitation in Low Vision Patients

The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial

Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning

Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) a Registry of High Cardiovascular Risk Subjects in the United States

Subject Evaluation of a 1064nm Diode Laser/RF

Working With HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation

A PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator Therapy

A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis

A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)

An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer